Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave
Identification of the risk factors and the high-risk groups which are most vulnerable is critical in COVID-19 disease management at a population level. Evaluating the efficacy of vaccination against infections is necessary to determine booster vaccination strategies for better protection in high-ris...
Saved in:
Published in | Scientific reports Vol. 13; no. 1; p. 19331 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
07.11.2023
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Identification of the risk factors and the high-risk groups which are most vulnerable is critical in COVID-19 disease management at a population level. Evaluating the efficacy of vaccination against infections is necessary to determine booster vaccination strategies for better protection in high-risk groups. In this study, we recruited 158 mRNA-vaccinated individuals during the Delta wave of SARS-CoV-2 infections in Singapore and examined the antibody profiles of infected individuals. We found that, despite high exposure due to communal living conditions in proximity, 4% of individuals (6/158) had PCR-confirmed infections and 96% (152/158) remained uninfected. Time-course analysis of the antibody profile at the start and the end of quarantine period showed Delta-specific boosting of anti-spike antibody response in 57% of the uninfected individuals (86/152). In the remaining 43% of the uninfected individuals (66/152) with no Delta-specific antibody boost, we found a higher Delta-specific antibody response at the start of quarantine period, which correlated with higher Delta pseudovirus neutralizing capacity. Our findings indicate that a higher basal variant-specific antibody response in the mRNA-vaccinated individuals contributes to better protection against infections by the new emerging SARS-CoV-2 variants. |
---|---|
AbstractList | Identification of the risk factors and the high-risk groups which are most vulnerable is critical in COVID-19 disease management at a population level. Evaluating the efficacy of vaccination against infections is necessary to determine booster vaccination strategies for better protection in high-risk groups. In this study, we recruited 158 mRNA-vaccinated individuals during the Delta wave of SARS-CoV-2 infections in Singapore and examined the antibody profiles of infected individuals. We found that, despite high exposure due to communal living conditions in proximity, 4% of individuals (6/158) had PCR-confirmed infections and 96% (152/158) remained uninfected. Time-course analysis of the antibody profile at the start and the end of quarantine period showed Delta-specific boosting of anti-spike antibody response in 57% of the uninfected individuals (86/152). In the remaining 43% of the uninfected individuals (66/152) with no Delta-specific antibody boost, we found a higher Delta-specific antibody response at the start of quarantine period, which correlated with higher Delta pseudovirus neutralizing capacity. Our findings indicate that a higher basal variant-specific antibody response in the mRNA-vaccinated individuals contributes to better protection against infections by the new emerging SARS-CoV-2 variants. Abstract Identification of the risk factors and the high-risk groups which are most vulnerable is critical in COVID-19 disease management at a population level. Evaluating the efficacy of vaccination against infections is necessary to determine booster vaccination strategies for better protection in high-risk groups. In this study, we recruited 158 mRNA-vaccinated individuals during the Delta wave of SARS-CoV-2 infections in Singapore and examined the antibody profiles of infected individuals. We found that, despite high exposure due to communal living conditions in proximity, 4% of individuals (6/158) had PCR-confirmed infections and 96% (152/158) remained uninfected. Time-course analysis of the antibody profile at the start and the end of quarantine period showed Delta-specific boosting of anti-spike antibody response in 57% of the uninfected individuals (86/152). In the remaining 43% of the uninfected individuals (66/152) with no Delta-specific antibody boost, we found a higher Delta-specific antibody response at the start of quarantine period, which correlated with higher Delta pseudovirus neutralizing capacity. Our findings indicate that a higher basal variant-specific antibody response in the mRNA-vaccinated individuals contributes to better protection against infections by the new emerging SARS-CoV-2 variants. |
ArticleNumber | 19331 |
Author | Chavatte, Jean-Marc Loh, Chiew Yee Lye, David C. Lim, Georgina Mohd Salleh, Siti Nazihah Tan, Yong Jie Chang, Zi Wei Hor, Pei Xiang Ngoh, Eve Zi Xian Lin, Raymond T. P. Rouers, Angeline Young, Barnaby Edward Goh, Yun Shan Wang, Bei Renia, Laurent Wang, Cheng-I Huang, Yuling Lee, Raphael Tze Chuen Fong, Siew-Wai Leo, Yee‐Sin Ng, Lisa F. P. Tay, Matthew Zirui Lam, Meng Chon Maurer-Stroh, Sebastian |
Author_xml | – sequence: 1 givenname: Yun Shan surname: Goh fullname: Goh, Yun Shan organization: ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR) – sequence: 2 givenname: Siew-Wai surname: Fong fullname: Fong, Siew-Wai organization: ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR) – sequence: 3 givenname: Matthew Zirui surname: Tay fullname: Tay, Matthew Zirui organization: ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR) – sequence: 4 givenname: Angeline surname: Rouers fullname: Rouers, Angeline organization: ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR) – sequence: 5 givenname: Zi Wei surname: Chang fullname: Chang, Zi Wei organization: ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR) – sequence: 6 givenname: Jean-Marc surname: Chavatte fullname: Chavatte, Jean-Marc organization: National Public Health Laboratory, National Centre for Infectious Diseases – sequence: 7 givenname: Pei Xiang surname: Hor fullname: Hor, Pei Xiang organization: ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR) – sequence: 8 givenname: Chiew Yee surname: Loh fullname: Loh, Chiew Yee organization: ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR) – sequence: 9 givenname: Yuling surname: Huang fullname: Huang, Yuling organization: ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR) – sequence: 10 givenname: Yong Jie surname: Tan fullname: Tan, Yong Jie organization: ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR) – sequence: 11 givenname: Bei surname: Wang fullname: Wang, Bei organization: Singapore Immunology Network, ASTAR – sequence: 12 givenname: Eve Zi Xian surname: Ngoh fullname: Ngoh, Eve Zi Xian organization: Singapore Immunology Network, ASTAR – sequence: 13 givenname: Siti Nazihah surname: Mohd Salleh fullname: Mohd Salleh, Siti Nazihah organization: Singapore Immunology Network, ASTAR – sequence: 14 givenname: Raphael Tze Chuen surname: Lee fullname: Lee, Raphael Tze Chuen organization: Bioinformatics Institute, ASTAR, GISAID Global Data Science Initiative (GISAID) – sequence: 15 givenname: Georgina surname: Lim fullname: Lim, Georgina organization: Ministry of Health (MOH) – sequence: 18 givenname: Sebastian surname: Maurer-Stroh fullname: Maurer-Stroh, Sebastian organization: ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR), National Public Health Laboratory, National Centre for Infectious Diseases, Bioinformatics Institute, ASTAR, GISAID Global Data Science Initiative (GISAID), Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Department of Biological Sciences, National University of Singapore – sequence: 19 givenname: Cheng-I surname: Wang fullname: Wang, Cheng-I organization: Singapore Immunology Network, ASTAR – sequence: 20 givenname: Yee‐Sin surname: Leo fullname: Leo, Yee‐Sin organization: National Centre for Infectious Diseases (NCID), Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Lee Kong Chian School of Medicine, Nanyang Technological University, Department of Infectious Diseases, Tan Tock Seng Hospital, Saw Swee Hock School of Public Health, National University of Singapore – sequence: 21 givenname: Raymond T. P. surname: Lin fullname: Lin, Raymond T. P. organization: National Public Health Laboratory, National Centre for Infectious Diseases, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore – sequence: 22 givenname: Meng Chon surname: Lam fullname: Lam, Meng Chon organization: Ministry of Health (MOH) – sequence: 23 givenname: David C. surname: Lye fullname: Lye, David C. organization: National Centre for Infectious Diseases (NCID), Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Lee Kong Chian School of Medicine, Nanyang Technological University, Department of Infectious Diseases, Tan Tock Seng Hospital – sequence: 24 givenname: Barnaby Edward surname: Young fullname: Young, Barnaby Edward organization: National Centre for Infectious Diseases (NCID), Lee Kong Chian School of Medicine, Nanyang Technological University, Department of Infectious Diseases, Tan Tock Seng Hospital – sequence: 25 givenname: Lisa F. P. surname: Ng fullname: Ng, Lisa F. P. organization: ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR), Health Protection Research Unit in Emerging and Zoonotic Infections, National Institute of Health Research, University of Liverpool, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool – sequence: 26 givenname: Laurent surname: Renia fullname: Renia, Laurent email: renia_laurent@idlabs.a-star.edu.sg organization: ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR), Lee Kong Chian School of Medicine, Nanyang Technological University, School of Biological Sciences, Nanyang Technological University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37935965$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kstu1DAUhiNUREvpC7BAkdiwCfgSJ85yVC6tVIHUAlvrxD6Z8ShjD7YzLTwPD4rTGQpigTe27M-fz5H_p8WR8w6L4jklrynh8k2sqehkRRiv6kYSUt09Kk4YqUXFOGNHf62Pi7MY1yQPwbqadk-KY952XHSNOCl-XtjlCkP5FscE5Q6CBZequEVtB6tLh1MKMNof1i3LfGJ7byzGchtwhy6hKa0bUCfrXV6VevQRS-1dAp1i1mltHczYrU2rLNAYZ1-5uf64OBxnm5nC7E8rLG8W1zfVuf9asUNJt7DDZ8XjAcaIZ4f5tPjy_t3n84vq6tOHy_PFVaVr3qSqabUZBsMHRNN0RHScUM4AUEgjsO8FbYWQhEE9tMaIhmIrGgRKG9NrPnT8tLjce42HtdoGu4HwXXmw6n7Dh6WCkKweUQ0aKAGUXNKuBlmD0brpgXPWY6NBZtervWsb_Lcpt602NmocR3Dop6iYlG3dSk54Rl_-g679FFzudKaaXHTuJlNsT-ngYww4PBRIiZojofaRUDkS6j4S6i5fenFQT_0GzcOV3wHIAN8DcTv_AYY_b_9H-wsRE8Zu |
Cites_doi | 10.1016/j.xcrm.2021.100193 10.1016/j.xpro.2021.100671 10.1038/s41541-021-00336-1 10.1038/s41591-022-01780-9 10.1038/s41586-021-04186-8 10.15252/emmm.202115227 10.1038/s41467-020-16638-2 10.1038/s41467-021-26154-6 10.1038/s41591-021-01377-8 10.1016/j.micinf.2021.104811 10.1038/s41541-021-00389-2 10.1371/journal.pone.0258820 10.1016/j.ijid.2020.11.148 10.1080/22221751.2022.2065936 10.1038/s41467-022-32312-1 10.1128/JVI.80.2.941-950.2006 10.1056/NEJMoa2109072 |
ContentType | Journal Article |
Contributor | Yu, Jocelyn Jin Chen, Wendy Yehui Amrun, Siti Naqiah Diong, Shiau Hui Torres-Ruesta, Anthony Libau, Eshele Anak Chua, Adeline C Y Lim, Jonathan Jordon Lim, Zhi Feng Sherman Ong, Alice Soh Meoy Ongko, Juwinda Abdullah, Mohammed Ridzwan Bin Yeo, Nicholas Kim-Wah Neo, Vanessa Kexin Soh, Zheng Kuang Teo, Jefanie Goh, Estelle Yi Wei Chin, Yi Qing Wong, Nathan Yeo, He Ping Kam, Isaac Kai Jie |
Contributor_xml | – sequence: 1 givenname: Jocelyn Jin surname: Yu fullname: Yu, Jocelyn Jin – sequence: 2 givenname: Zheng Kuang surname: Soh fullname: Soh, Zheng Kuang – sequence: 3 givenname: Yi Qing surname: Chin fullname: Chin, Yi Qing – sequence: 4 givenname: Jonathan Jordon surname: Lim fullname: Lim, Jonathan Jordon – sequence: 5 givenname: Juwinda surname: Ongko fullname: Ongko, Juwinda – sequence: 6 givenname: Eshele Anak surname: Libau fullname: Libau, Eshele Anak – sequence: 7 givenname: Mohammed Ridzwan Bin surname: Abdullah fullname: Abdullah, Mohammed Ridzwan Bin – sequence: 8 givenname: Shiau Hui surname: Diong fullname: Diong, Shiau Hui – sequence: 9 givenname: Jefanie surname: Teo fullname: Teo, Jefanie – sequence: 10 givenname: He Ping surname: Yeo fullname: Yeo, He Ping – sequence: 11 givenname: Adeline C Y surname: Chua fullname: Chua, Adeline C Y – sequence: 12 givenname: Anthony surname: Torres-Ruesta fullname: Torres-Ruesta, Anthony – sequence: 13 givenname: Siti Naqiah surname: Amrun fullname: Amrun, Siti Naqiah – sequence: 14 givenname: Nicholas Kim-Wah surname: Yeo fullname: Yeo, Nicholas Kim-Wah – sequence: 15 givenname: Vanessa Kexin surname: Neo fullname: Neo, Vanessa Kexin – sequence: 16 givenname: Wendy Yehui surname: Chen fullname: Chen, Wendy Yehui – sequence: 17 givenname: Isaac Kai Jie surname: Kam fullname: Kam, Isaac Kai Jie – sequence: 18 givenname: Alice Soh Meoy surname: Ong fullname: Ong, Alice Soh Meoy – sequence: 19 givenname: Estelle Yi Wei surname: Goh fullname: Goh, Estelle Yi Wei – sequence: 20 givenname: Nathan surname: Wong fullname: Wong, Nathan – sequence: 21 givenname: Zhi Feng Sherman surname: Lim fullname: Lim, Zhi Feng Sherman |
Copyright | The Author(s) 2023. corrected publication 2024 2023. The Author(s). The Author(s) 2023. corrected publication 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2023. corrected publication 2024 – notice: 2023. The Author(s). – notice: The Author(s) 2023. corrected publication 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
CorporateAuthor | COVID-Study Group NCID Study Group |
CorporateAuthor_xml | – sequence: 0 name: COVID-Study Group – sequence: 0 name: NCID Study Group – name: COVID-Study Group – name: NCID Study Group |
DBID | C6C CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PIMPY PQEST PQQKQ PQUKI Q9U 7X8 DOA |
DOI | 10.1038/s41598-023-46800-x |
DatabaseName | SpringerOpen Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Medical Database Science Database (ProQuest) Biological Science Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology Medicine Public Health |
EISSN | 2045-2322 |
EndPage | 19331 |
ExternalDocumentID | oai_doaj_org_article_fca10ae838194a84adcc6ba332be6ca8 10_1038_s41598_023_46800_x 37935965 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: U.S. Food and Drug Administration grantid: (#75F40120C00085; (#75F40120C00085 funderid: http://dx.doi.org/10.13039/100000038 – fundername: Singapore National Medical Research Council grantid: COVID19RF-0001; COVID19RF-007; COVID19RF-0008; COVID19RF-0011; COVID19RF-0060; COVID19RF-0001; COVID19RF-007; COVID19RF-0008; COVID19RF-0011; COVID19RF-0060; COVID19RF-0001; COVID19RF-007; COVID19RF-0008; COVID19RF-0011; COVID19RF-0060 – fundername: Agency for Science, Technology and Research (A*STAR), Singapore grantid: SC35/22-805100; ACCL/19-GAP064-R20H-H; H/20/04/g1/006; ACCL/19-GAP064-R20H-H; H/20/04/g1/006 |
GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ADBBV ADRAZ AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RIG RNT RNTTT RPM SNYQT UKHRP CGR CUY CVF ECM EIF NPM AAYXX CITATION 7XB 8FK K9. PQEST PQUKI Q9U 7X8 |
ID | FETCH-LOGICAL-c436t-67cdffd3feed6905930132aae58d5ebb51755802a4f7dd561e756ea116dbc3f93 |
IEDL.DBID | M48 |
ISSN | 2045-2322 |
IngestDate | Tue Oct 22 15:10:34 EDT 2024 Tue Dec 03 23:55:58 EST 2024 Fri Nov 08 20:51:54 EST 2024 Fri Dec 06 05:47:13 EST 2024 Sat Nov 02 12:19:34 EDT 2024 Fri Oct 11 20:48:11 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2023. The Author(s). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c436t-67cdffd3feed6905930132aae58d5ebb51755802a4f7dd561e756ea116dbc3f93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-023-46800-x |
PMID | 37935965 |
PQID | 2886755690 |
PQPubID | 2041939 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_fca10ae838194a84adcc6ba332be6ca8 proquest_miscellaneous_2887478303 proquest_journals_2886755690 crossref_primary_10_1038_s41598_023_46800_x pubmed_primary_37935965 springer_journals_10_1038_s41598_023_46800_x |
PublicationCentury | 2000 |
PublicationDate | 2023-11-07 |
PublicationDateYYYYMMDD | 2023-11-07 |
PublicationDate_xml | – month: 11 year: 2023 text: 2023-11-07 day: 07 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Scientific reports |
PublicationTitleAbbrev | Sci Rep |
PublicationTitleAlternate | Sci Rep |
PublicationYear | 2023 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | Alishaq (CR3) 2021; 16 Yang (CR6) 2022; 11 Tay (CR16) 2022; 14 Goh, Ng, Renia (CR12) 2021; 2 Renia (CR15) 2022; 13 Killingley (CR9) 2022; 28 McDonald, Murray, Reynolds, Altmann, Boyton (CR2) 2021; 6 Goh (CR8) 2021; 2 Lip (CR17) 2006; 80 Swadling (CR10) 2022; 601 Rovida (CR5) 2021; 12 Bergwerk (CR4) 2021; 385 Gorny (CR7) 2021; 103 Hotez, Nuzhath, Callaghan, Colwell (CR1) 2021; 23 Wang (CR13) 2021; 6 Poh (CR14) 2020; 11 Khoury (CR11) 2021; 27 38233454 - Sci Rep. 2024 Jan 17;14(1):1492 B Wang (46800_CR13) 2021; 6 YS Goh (46800_CR8) 2021; 2 M Bergwerk (46800_CR4) 2021; 385 L Renia (46800_CR15) 2022; 13 PJ Hotez (46800_CR1) 2021; 23 CM Poh (46800_CR14) 2020; 11 AW Gorny (46800_CR7) 2021; 103 YS Goh (46800_CR12) 2021; 2 B Killingley (46800_CR9) 2022; 28 I McDonald (46800_CR2) 2021; 6 MZ Tay (46800_CR16) 2022; 14 M Alishaq (46800_CR3) 2021; 16 F Rovida (46800_CR5) 2021; 12 L Swadling (46800_CR10) 2022; 601 SL Yang (46800_CR6) 2022; 11 DS Khoury (46800_CR11) 2021; 27 KM Lip (46800_CR17) 2006; 80 |
References_xml | – volume: 2 year: 2021 ident: CR8 article-title: Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19 publication-title: Cell Rep Med doi: 10.1016/j.xcrm.2021.100193 contributor: fullname: Goh – volume: 2 year: 2021 ident: CR12 article-title: A flow cytometry-based assay for serological detection of anti-spike antibodies in COVID-19 patients publication-title: STAR Protoc doi: 10.1016/j.xpro.2021.100671 contributor: fullname: Renia – volume: 6 start-page: 74 year: 2021 ident: CR2 article-title: Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2 publication-title: NPJ Vaccines doi: 10.1038/s41541-021-00336-1 contributor: fullname: Boyton – volume: 28 start-page: 1031 year: 2022 end-page: 1041 ident: CR9 article-title: Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults publication-title: Nat Med doi: 10.1038/s41591-022-01780-9 contributor: fullname: Killingley – volume: 601 start-page: 110 year: 2022 end-page: 117 ident: CR10 article-title: Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 publication-title: Nature doi: 10.1038/s41586-021-04186-8 contributor: fullname: Swadling – volume: 14 year: 2022 ident: CR16 article-title: Decreased memory B cell frequencies in COVID-19 delta variant vaccine breakthrough infection publication-title: EMBO Mol Med doi: 10.15252/emmm.202115227 contributor: fullname: Tay – volume: 11 start-page: 2806 year: 2020 ident: CR14 article-title: Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients publication-title: Nat Commun doi: 10.1038/s41467-020-16638-2 contributor: fullname: Poh – volume: 12 start-page: 6032 year: 2021 ident: CR5 article-title: SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers publication-title: Nat Commun doi: 10.1038/s41467-021-26154-6 contributor: fullname: Rovida – volume: 27 start-page: 1205 year: 2021 end-page: 1211 ident: CR11 article-title: Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection publication-title: Nat Med doi: 10.1038/s41591-021-01377-8 contributor: fullname: Khoury – volume: 23 year: 2021 ident: CR1 article-title: COVID-19 vaccine decisions: considering the choices and opportunities publication-title: Microbes Infect doi: 10.1016/j.micinf.2021.104811 contributor: fullname: Colwell – volume: 6 start-page: 125 year: 2021 ident: CR13 article-title: Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore publication-title: NPJ Vaccines doi: 10.1038/s41541-021-00389-2 contributor: fullname: Wang – volume: 16 year: 2021 ident: CR3 article-title: Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers publication-title: PLoS One doi: 10.1371/journal.pone.0258820 contributor: fullname: Alishaq – volume: 103 start-page: 389 year: 2021 end-page: 394 ident: CR7 article-title: SARS-CoV-2 in migrant worker dormitories: Geospatial epidemiology supporting outbreak management publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.11.148 contributor: fullname: Gorny – volume: 11 start-page: 1262 year: 2022 end-page: 1271 ident: CR6 article-title: COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in Malaysia publication-title: Emerg Microbes Infect doi: 10.1080/22221751.2022.2065936 contributor: fullname: Yang – volume: 13 start-page: 4615 year: 2022 ident: CR15 article-title: Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose publication-title: Nat Commun doi: 10.1038/s41467-022-32312-1 contributor: fullname: Renia – volume: 80 start-page: 941 year: 2006 end-page: 950 ident: CR17 article-title: Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus publication-title: J Virol doi: 10.1128/JVI.80.2.941-950.2006 contributor: fullname: Lip – volume: 385 start-page: 1474 year: 2021 end-page: 1484 ident: CR4 article-title: Covid-19 breakthrough infections in vaccinated health care workers publication-title: N Engl J Med doi: 10.1056/NEJMoa2109072 contributor: fullname: Bergwerk – volume: 12 start-page: 6032 year: 2021 ident: 46800_CR5 publication-title: Nat Commun doi: 10.1038/s41467-021-26154-6 contributor: fullname: F Rovida – volume: 80 start-page: 941 year: 2006 ident: 46800_CR17 publication-title: J Virol doi: 10.1128/JVI.80.2.941-950.2006 contributor: fullname: KM Lip – volume: 14 year: 2022 ident: 46800_CR16 publication-title: EMBO Mol Med doi: 10.15252/emmm.202115227 contributor: fullname: MZ Tay – volume: 2 year: 2021 ident: 46800_CR12 publication-title: STAR Protoc doi: 10.1016/j.xpro.2021.100671 contributor: fullname: YS Goh – volume: 13 start-page: 4615 year: 2022 ident: 46800_CR15 publication-title: Nat Commun doi: 10.1038/s41467-022-32312-1 contributor: fullname: L Renia – volume: 385 start-page: 1474 year: 2021 ident: 46800_CR4 publication-title: N Engl J Med doi: 10.1056/NEJMoa2109072 contributor: fullname: M Bergwerk – volume: 601 start-page: 110 year: 2022 ident: 46800_CR10 publication-title: Nature doi: 10.1038/s41586-021-04186-8 contributor: fullname: L Swadling – volume: 11 start-page: 1262 year: 2022 ident: 46800_CR6 publication-title: Emerg Microbes Infect doi: 10.1080/22221751.2022.2065936 contributor: fullname: SL Yang – volume: 16 year: 2021 ident: 46800_CR3 publication-title: PLoS One doi: 10.1371/journal.pone.0258820 contributor: fullname: M Alishaq – volume: 27 start-page: 1205 year: 2021 ident: 46800_CR11 publication-title: Nat Med doi: 10.1038/s41591-021-01377-8 contributor: fullname: DS Khoury – volume: 6 start-page: 74 year: 2021 ident: 46800_CR2 publication-title: NPJ Vaccines doi: 10.1038/s41541-021-00336-1 contributor: fullname: I McDonald – volume: 2 year: 2021 ident: 46800_CR8 publication-title: Cell Rep Med doi: 10.1016/j.xcrm.2021.100193 contributor: fullname: YS Goh – volume: 11 start-page: 2806 year: 2020 ident: 46800_CR14 publication-title: Nat Commun doi: 10.1038/s41467-020-16638-2 contributor: fullname: CM Poh – volume: 28 start-page: 1031 year: 2022 ident: 46800_CR9 publication-title: Nat Med doi: 10.1038/s41591-022-01780-9 contributor: fullname: B Killingley – volume: 23 year: 2021 ident: 46800_CR1 publication-title: Microbes Infect doi: 10.1016/j.micinf.2021.104811 contributor: fullname: PJ Hotez – volume: 103 start-page: 389 year: 2021 ident: 46800_CR7 publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2020.11.148 contributor: fullname: AW Gorny – volume: 6 start-page: 125 year: 2021 ident: 46800_CR13 publication-title: NPJ Vaccines doi: 10.1038/s41541-021-00389-2 contributor: fullname: B Wang |
SSID | ssj0000529419 |
Score | 2.463039 |
Snippet | Identification of the risk factors and the high-risk groups which are most vulnerable is critical in COVID-19 disease management at a population level.... Abstract Identification of the risk factors and the high-risk groups which are most vulnerable is critical in COVID-19 disease management at a population... |
SourceID | doaj proquest crossref pubmed springer |
SourceType | Open Website Aggregation Database Index Database Publisher |
StartPage | 19331 |
SubjectTerms | 631/250 692/308 692/699 Antibodies Antibodies, Neutralizing Antibodies, Viral COVID-19 COVID-19 - prevention & control COVID-19 vaccines Dormitories Humanities and Social Sciences Humans Immunization Immunology Infections Infectious diseases Living conditions Medicine mRNA mRNA Vaccines multidisciplinary Public health Quarantine Risk factors RNA, Messenger - genetics SARS-CoV-2 Science Science (multidisciplinary) Severe acute respiratory syndrome coronavirus 2 Vaccination |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA9SELyI365WieBNQ3fztbvHZ7UUwR5aK70tk2QWCnW39O2r1b_HP9RJsu9ZUfHibdmEIclMmN9kvhh7qa0C1TdOoKmC0A68aLVEUXqLBA8ChFRi48OB3T_W70_MybVWXzEmLJcHzge303uoSsAmWhYaGg3Be-tAKenQeshpvqW8Zkzlqt6y1VU7Z8mUqtlZkqaK2WRSCW0JJYmrXzRRKtj_J5T5m4c0KZ69O-z2jBj5Iq_0LruBwz12M_eQ_Hqffc-RGvwtnk3AL8n0pbMSMYEyBgHxAVfpLeMb0eY0curGGDfIz3PpJgx8HY410Bf3Z-MSeYxfBz8tiZz3pwPEafHBlkcRSW8j_PPhwWIeJmo52ZETmORHi8MjsTt-EnJe0he4xAfseO_dx919MbdeEF4rOwlb-9D3QfWkQsl-Nq2KPhkANE0w6Jwh1GGaUoLu6xAIg2FtLEJV2eC86lv1kG0N44CPGQdXe2VrGTT0Ggw47ANxAslO9NKFtmCv1mzoznOFjS55xlXTZaZ1xLQuMa27KtibyKnNzFgdO_0gmelmmen-JTMF217zuZuv7LKTTUPGk6HdFuzFZpguW_SgwIDjKs2J_QZI7RfsUZaPzUpUHZOcrSnY67XA_CT-9w09-R8bespuySjZ8bm73mZb08UKnxFYmtzzdC9-APoTFNQ priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFD6CTiAkhKDcAgMZiTew1sSXuE-oG5smpFWoY2hv0fElCGkkZW3H4PfwQzlO3E6Iy1sUW7aTc2x_5w7wUmqBojaWB5V7Li06PpZF4COnA8EDj75LsXE01Ycn8t2pOk0Kt0Vyq1yfid1B7VsXdeQ7hTGEbRUJc2_mX3msGhWtq6mExnXYKnJhzAC2dven72cbLUu0Y8l8nKJlRsLsLOjGilFlheBSE1ril7_dSF3i_r-hzT8spd0FdHAX7iTkyCY9qe_BtdAM4UZfS_L7EG4eJSv5EG73ujjWhxjdh5-9Mwd7G86WyC5IOqbfyWOMZfQTYk1YdeqOHzQto5bPto2uhWzeZ3cKnq09thp6Yu6sXQQWXdzRLRc0nKNZMXaLOl0WuahTn7Avs-kkNdNofTwkI7zJjiezY77XfuRFWtI3vAgP4ORg_8PeIU_VGbiTQi-5Lp2vay9qumWJKmosotkGMSjjVbBWETBRZlSgrEvvCaaFUumAea69daIei4cwaNomPAaGtnRCl4WXWEtUaEPtiUiBRElXWD_O4NWaQtW8T8JRdcZzYaqenhXRs-roWV1msBuJuOkZE2h3L9rzT1Xaj1XtMB9hMFFglWgkeue0RSEKG7RDk8H2mgWqtKsX1RUPZvBi00z7MRpZsAntqusTSxIQMsjgUc86m5WIMsZBa5XB6zUvXQ3-7w968v-1PIVbRWTnqOsut2GwPF-FZ4SUlvZ52g6_ALx7FJA priority: 102 providerName: ProQuest – databaseName: SpringerOpen dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZQERIXxJvQFhmJG1hs4kec43ahqpDooaWoN2tsT6RKbVKx2QL9PfxQxk52UUU5cIviiWVnxppvnmbsjTISZGu9QF1GoTwE0agKxSwYJHgQIeYWG58PzcGJ-nSqT6c2OakW5kb8Xtr3S1IwqQiskkIZAjeC8OJd0sF1kuaFWWz8KSlipcpmqou5_dMbuie36L8NV_4VE82qZv8hezBhRD4fmfqI3cHuMbs33hr58wn7NeZm8A94PgC_ImOX_o5IJZMp7Yd3uMrei2uam9PIme9TpiC_HJs1YeTrBKyOnng475fIU8Y6hGFJ04Vw1kEiSy5anoQie0P4xdHhfBqm2cbyRk7wkR_Pj47Fov8qqmlJ3-EKn7KT_Y9fFgdiumxBBCXNIEwdYttG2ZLSJItZNzJFYQBQ26jRe004Q9tZBaqtYyTUhbU2CGVpog-ybeQzttX1Hb5gHHwdpKmrqKBVoMFjG4kTSJZhqHxsCvZ2zQZ3OfbUcDkWLq0bmeaIaS4zzf0o2F7i1IYy9cPOL0hM3HS8XBugnAHaZH8qsApiCMaDlJVHE8AWbGfNZzcd0qWrrCVzSdNuC_Z6M0zHK8VMoMN-lWnSDQOk6Av2fJSPzUpkncqajS7Yu7XA_Jn83xt6-X_k2-x-uuI-1z_WO2xr-LbCXQJCg3-VT8Bv3M0EUA priority: 102 providerName: Springer Nature |
Title | Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave |
URI | https://link.springer.com/article/10.1038/s41598-023-46800-x https://www.ncbi.nlm.nih.gov/pubmed/37935965 https://www.proquest.com/docview/2886755690 https://search.proquest.com/docview/2887478303 https://doaj.org/article/fca10ae838194a84adcc6ba332be6ca8 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKKyQuiDcpZWUkbmDY9SvJAaHt0qpC6gptWbS3aPwIqrQk7T5Ky-_hhzJ2kkWI5cAtiR3L9ow134znQchLqQWIMjPMq4Fj0oBlueSe9a32CA8cuJhi43SsT6by40zNdkhX7qjdwOVW1S7Uk5ou5m-uL2_e44F_14SMZ2-XKIRCoBgXTGoEQAwx5R5HyRhcvE5buN_k-ua5HORt7Mz2X_-QTzGN_zbs-de9aRRHx_fI3RZH0mFD-Ptkx1cPyO2msuTNQ_Kz8d-gH_x8BfQKFWLcQRbCKoNrEK38Olo4fuDYFFvOTR28CelFk9DJO9o5aVX4RO28XnoavNrBrpY4nLXnFYRuwYxLA-NEiwn9NhkP22YcrQmBpAgx6dlwcsZG9RfG2yl9hyv_iEyPjz6PTlhbkIFZKfSK6dS6snSiRMGKWrXKRbipAfAqc8oboxCLqKzPQZapc4jMfKq0h8FAO2NFmYvHZLeqK_-UUDCpFTrlTkIpQYHxpUNKeNQeLTcuT8irjgzFRZN3o4j35SIrGqIVSLQiEq24TshhoNSmZ8iZHT_Ui69FewSL0sKgDz4LOqqETIKzVhsQghuvLWQJOejoXHR8WPAsQ5VK4WoT8mLTjEcw3KtA5et17BOqECAYSMiThj82MxFpCH3WKiGvO4b5Pfi_F7T_f92fkTs88HAwd6cHZHe1WPvnCJZWpkdupbO0R_YOj8afJvg20qNeNDz04tn4BcSnFyo |
link.rule.ids | 314,780,784,864,2102,12056,21388,24318,27924,27925,31719,31720,33744,33745,41120,42189,43310,43805,51576,73745,74302 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFD6CTlwkhKAMCAwwEm9grY0vSZ9QNzYVWCvUbWhv0fElCGkkZW3H4PfwQzlO3E6Iy1sUW7aTc2x_5w7wQmqBoswN96rvuDRo-UCmnves9gQPHLomxcZ4okfH8t2JOokKt3l0q1ydic1B7WobdOTbaZ4TtlUkzL2efeWhalSwrsYSGldhI2ROVx3Y2NmbfJiutSzBjiX7gxgt0xP59pxurBBVlgouNaElfvHbjdQk7v8b2vzDUtpcQPt34HZEjmzYkvouXPFVF661tSS_d-H6OFrJu3Cr1cWxNsToHvxsnTnYG3-6QHZO0jH9Th5iLIOfEKv8slF3_KBpGbV8NnVwLWSzNruTd2zlsVXRE7On9dyz4OKOdjGn4SzNiqFb0OmywEWN-oR9mU6GsZlGa-MhGeFNdjicHvLd-iNP45K-4bnfhOP9vaPdEY_VGbiVQi-4zqwrSydKumWJKmoggtkG0avcKW-MImCi8l6KssycI5jmM6U99vvaGSvKgbgPnaqu_ENgaDIrdJY6iaVEhcaXjojkSZS0qXGDBF6uKFTM2iQcRWM8F3nR0rMgehYNPYuLBHYCEdc9QwLt5kV99qmI-7EoLfZ76PMgsErMJTprtUEhUuO1xTyBrRULFHFXz4tLHkzg-bqZ9mMwsmDl62XTJ5QkIGSQwIOWddYrEVmIg9YqgVcrXroc_N8f9Oj_a3kGN0ZH44Pi4O3k_WO4mQbWDnrvbAs6i7Olf0KoaWGexq3xC8xcF3g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Zb9NAEB5BKiokhCBQMBRYJN5glcR72HlC6RGVo1GVUtQ3a_YwQip2aJJS-D38UGbtTSrE8WZ5V-u1Z8bz7ZwAL6QWKMrccK8GjkuDlg9l6nnfak_wwKFrSmwcTvTBiXx7qk5j_NM8hlWu_onNj9rVNtjIe2meE7ZVdJjrlTEs4mhv_Hr2lYcOUsHTGttpXIcN0or9tAMbO_uTo-na4hJ8WnIwjJkzfZH35qS9QoZZKrjUhJz45W_aqSni_zfk-YfXtFFG4ztwO6JINmrJfheu-aoLN9q-kt-7sHkYPeZduNXa5VibbnQPfraBHWzPny2QXdBJmT4tD_mWIWaIVX7ZmD5-0GMZjXw2dQgzZLO20pN3bBW9VdEVs2f13LMQ7o52MaflLD0Vw7Rg32WBoxpTCvsynYziMK3W5kYywp7seDQ95rv1R57GLX3DC38fTsb7H3YPeOzUwK0UesF1Zl1ZOlGSxiUKqaEILhxEr3KnvDGKQIrK-ynKMnOOIJvPlPY4GGhnrCiHYgs6VV35h8DQZFboLHUSS4kKjS8dEcnTsdKmxg0TeLmiUDFrC3IUjSNd5EVLz4LoWTT0LC4T2AlEXM8MxbSbG_X5pyLKZlFaHPTR5-HwKjGX6KzVBoVIjdcW8wS2VyxQRAmfF1f8mMDz9TDJZnC4YOXrZTMntCcglJDAg5Z11jsRWciJ1iqBVyteulr83y_06P97eQabJBXF-zeTd4_hZho4O5jAs23oLM6X_gkBqIV5GiXjF83YG6U |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Higher+Delta+variant-specific+neutralizing+antibodies+prevented+infection+in+close+contacts+vaccinated+with+ancestral+mRNA+vaccines+during+the+SARS-CoV-2+Delta+wave&rft.jtitle=Scientific+reports&rft.au=Goh%2C+Yun+Shan&rft.au=Fong%2C+Siew-Wai&rft.au=Tay%2C+Matthew+Zirui&rft.au=Rouers%2C+Angeline&rft.date=2023-11-07&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-023-46800-x&rft.externalDocID=10_1038_s41598_023_46800_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |